A Resazurin Reduction-Based Assay for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii and Pseudomonas aeruginosa.

Acinetobacter baumannii / drug effects Anti-Bacterial Agents / pharmacology Drug Resistance, Bacterial Humans Microbial Sensitivity Tests / economics Oxazines Polymyxins / pharmacology Pseudomonas aeruginosa / drug effects Sensitivity and Specificity Time Factors Xanthenes
Acinetobacter baumannii Pseudomonas aeruginosa colistin rapid diagnostic test susceptibility testing

Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
03 2019
Historique:
received: 25 09 2018
accepted: 13 12 2018
pubmed: 21 12 2018
medline: 29 5 2020
entrez: 21 12 2018
Statut: epublish

Résumé

A rapid test was developed for identification of polymyxin resistance in nonfermenting bacteria. This test detects viable cells after growth in a medium containing a defined concentration of colistin. The principle of this test is based on the visual detection of the reduction of the resazurin reagent, a viability colorant, as observed by its color change (blue to purple or pink). Its evaluation was performed by using 92 colistin-resistant and colistin-susceptible

Identifiants

DOI: 10.1128/JCM.01563-18 PMID: 30567745 PMC: PMC6425163
pubmed: 30567745
pii: JCM.01563-18
doi: 10.1128/JCM.01563-18
pmc: PMC6425163
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Oxazines 0
Polymyxins 0
Xanthenes 0
resazurin 1FN9YD6968

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Future Microbiol. 2013 Jun;8(6):711-24
pubmed: 23701329
Eur J Biochem. 2000 Sep;267(17):5421-6
pubmed: 10951200
Clin Infect Dis. 2009 Jan 1;48(1):1-12
pubmed: 19035777
Clin Microbiol Infect. 2018 Feb;24(2):175-179
pubmed: 28606644
J Microbiol. 2017 Nov;55(11):837-849
pubmed: 29076065
Clin Microbiol Infect. 2017 Oct;23(10):704-712
pubmed: 28893690
Diagn Microbiol Infect Dis. 2018 Dec;92(4):267-269
pubmed: 30220493
J Clin Microbiol. 2013 Jun;51(6):1678-84
pubmed: 23486719
Clin Microbiol Infect. 2007 May;13(5):541-4
pubmed: 17371537
JAMA. 2009 Dec 2;302(21):2323-9
pubmed: 19952319
Emerg Infect Dis. 2016 Jun;22(6):1038-43
pubmed: 27191712
Nature. 2017 Feb 28;543(7643):15
pubmed: 28252092

Auteurs

Mathilde Lescat (M)

Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
INSERM European Unit (LEA, IAME), Paris, France.
Université Paris Nord, Sorbonne Paris Cité, Paris, France.
AP-HP, Hôpitaux Universitaires Paris Seine Saint-Denis, Paris, France.

Laurent Poirel (L)

Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
INSERM European Unit (LEA, IAME), Paris, France.
Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.

Camille Tinguely (C)

Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
INSERM European Unit (LEA, IAME), Paris, France.
Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.

Patrice Nordmann (P)

Emerging Antibiotic Resistance Unit, Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland patrice.nordmann@unifr.ch.
INSERM European Unit (LEA, IAME), Paris, France.
Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.
University of Lausanne and University Hospital Center, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Moraxellaceae › Acinetobacter › Acinetobacter baumannii › A Resazurin Reduction-Based Assay for Rapid...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › A Resazurin Reduction-Based Assay for Rapid...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › A Resazurin Reduction-Based Assay for Rapid...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › A Resazurin Reduction-Based Assay for Rapid...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › A Resazurin Reduction-Based Assay for Rapid...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Oxazines › A Resazurin Reduction-Based Assay for Rapid...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Perforines › Peptides antimicrobiens cationiques › Polymyxines › A Resazurin Reduction-Based Assay for Rapid...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Pseudomonadaceae › Pseudomonas › Pseudomonas aeruginosa › A Resazurin Reduction-Based Assay for Rapid...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Sensibilité et spécificité › A Resazurin Reduction-Based Assay for Rapid...
questionsmedicales.fr › Phénomènes physiques › Temps › Facteurs temps › A Resazurin Reduction-Based Assay for Rapid...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérocycliques 3 noyaux › Xanthènes › A Resazurin Reduction-Based Assay for Rapid...